CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome

Friday, November 2
11:35 AM - 12:35 PM
Location: Grand Ballroom

BCOP CE

Learning Objectives:

ViewAttendees 23 Slides Take Notes

Jae Park, MD

Assistant Attending Physician
Memorial Sloan Kettering Cancer Center

Jae Park, MD is Assistant Attending Physician in the Division of Hematologic Oncology, Leukemia Service, and a Clinical Director of Cellular Therapeutics Centers at the Memorial Sloan Kettering Cancer Center in New York. Dr. Park received his medical degree from the Johns Hopkins School of Medicine and completed an internal medicine residency at Massachusetts General Hospital and a hematology/oncology fellowship at Memorial Sloan Kettering Cancer Center. Dr. Park has written numerous peer-reviewed articles appearing in New England Journal of Medicine, Science Translational Medicine, Blood, Cancer Discovery and Journal of Clinical Oncology. His research has been recognized and funded by the AACR, ASH, ASCO, Leukemia and Lymphoma Society, Geoffrey Beene Research Foundation, and NCCN. He is the Director of MSK adult ALL program and his research focus is to translate and establish novel targeted and immunotherapies for patients with hematologic malignancies using CD19-CAR T cells, BiTEs, oral targeted agents, and immunomodulators.

Presentation(s):

ViewAttendees 23 Slides Take Notes

Send Email for Jae Park

Amber C. King, PharmD, BCOP

Leukemia Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center

Amber C. King, PharmD, BCOP is a Leukemia Clinical Pharmacy Specialist at Memorial Sloan Kettering Cancer Center in New York. She received her Doctor of Pharmacy degree in 2013 from Northeastern University in Boston, MA. She completed an ASHP accredited PGY1 Pharmacy Residency at UT MD Anderson Cancer Center in Houston, TX and an ASHP accredited PGY2 Oncology Pharmacy Residency at Memorial Sloan Kettering Cancer Center. Her clinical interests include outcomes research in myeloproliferative neoplasms, myeloid leukemias, and lymphoid leukemias, guideline and treatment algorithm development, investigational protocol development, and mentorship of pharmacy residents and students.

Presentation(s):

ViewAttendees 23 Slides Take Notes

Send Email for Amber King

Christopher Campen, PharmD BCOP

Clinical Pharmacist
Greenville Health System Cancer Institute

Christopher J. Campen, PharmD, BCOP, is a clinical oncology pharmacist at Greenville Health System in Greenville, South Carolina where he specializes in stem cell transplant and hematologic malignancies. He previously worked for the University of Arizona Cancer Center in Tucson, Arizona. Chris is an Associate Editor for JADPRO, a Conference Co-Chair for JADPRO Live at APSHO, and has been actively involved with the Hematology Oncology Pharmacist Association (HOPA). He is married with 3 kids and enjoys triathlons and mountain biking.

Presentation(s):

ViewAttendees 23 Slides Take Notes

Send Email for Christopher Campen


Assets

CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome